Group 1 - The core business of the company is as a service provider, primarily offering labor dispatch and supporting services to construction contractors in Singapore, along with dormitory services, IT services, and construction support services [2] - The company aims to leverage the advantages of both Hong Kong and Singapore to actively expand its existing business, enter new industries, and seek investment cooperation opportunities to enhance long-term returns for shareholders and improve business prospects [2] Group 2 - As of August 14, the company's stock price increased by 20.0% to HKD 1.8 per share, with a trading volume of 22.13 million shares and a turnover of HKD 33.81 million, showing a volatility of 25.33% [1] - Financial data indicates that for the year ending December 31, 2024, the company achieved total revenue of HKD 267 million, a year-on-year increase of 10.07%, while the net profit attributable to shareholders was a loss of HKD 95.6 million, a decrease of 471.95% [1] - The company's gross profit margin stands at 22.84%, and its debt-to-asset ratio is 44.32% [1] - Currently, there are no institutional investment ratings for the company's stock [1] - The company's price-to-earnings ratio is -75.12, ranking 57th in the industry, while the average price-to-earnings ratio for the support services industry is 5.63 [1]
今海医疗科技（02225.HK）8月14日收盘上涨20.0%，成交3380.66万港元